非甾体抗炎药综述。
A review of non-steroidal anti-inflammatory drugs.
出版信息
Can Fam Physician. 1983 Nov;29:2121-4.
Abstract
An increasing number of non-steroidal anti-inflammatory drugs (NSAIDs) is available for clinical use each year. This article reviews significant differences between NSAIDs currently available in Canada, and helps the clinician to evaluate new NSAIDs. While their mechanism of action and efficacy are similar, side effects and cost vary considerably from one agent to another. Because all NSAIDs can produce adverse effects, patients, especially if they are elderly, should be selected carefully for treatment with a particular agent.
摘要
每年都有越来越多的非甾体抗炎药（NSAIDs）可供临床使用。本文综述了加拿大目前可用的 NSAIDs 之间的显著差异，帮助临床医生评估新的 NSAIDs。虽然它们的作用机制和疗效相似，但副作用和成本在不同药物之间有很大差异。由于所有 NSAIDs 都可能产生不良反应，因此患者，特别是老年人，应谨慎选择特定药物进行治疗。
相似文献
1
A review of non-steroidal anti-inflammatory drugs.非甾体抗炎药综述。
Can Fam Physician. 1983 Nov;29:2121-4.
2
Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.环氧化酶-2选择性非甾体抗炎药（依托度酸、美洛昔康、塞来昔布、罗非昔布、艾瑞昔布、伐地昔布和鲁米昔布）用于骨关节炎和类风湿性关节炎：系统评价与经济学评估
Health Technol Assess. 2008 Apr;12(11):1-278, iii. doi: 10.3310/hta12110.
3
Non-steroidal anti-inflammatory drugs (NSAIDs) for cancer-related pain in children and adolescents.用于儿童和青少年癌症相关疼痛的非甾体抗炎药（NSAIDs）
Cochrane Database Syst Rev. 2017 Jul 24;7(7):CD012563. doi: 10.1002/14651858.CD012563.pub2.
4
Should nonsteroidal anti-inflammatory drugs (NSAIDs) be prescribed to the older adult?老年人是否应该开非甾体抗炎药（NSAIDs）？
Drugs Aging. 2010 Oct 1;27(10):775-89. doi: 10.2165/11539430-000000000-00000.
6
Nonsteroidal anti-inflammatory drugs in the elderly.老年人使用非甾体抗炎药
Pain Manag Nurs. 2000 Jun;1(2):40-50. doi: 10.1053/jpmn.2000.7779.
7
Is there scope for improving the cost-effective prescribing of nonsteroidal anti-inflammatory drugs?提高非甾体抗炎药的成本效益处方是否有空间？
Pharmacoeconomics. 1996 Jun;9(6):484-96. doi: 10.2165/00019053-199609060-00003.
8
A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling.五种预防非甾体抗炎药所致胃肠道毒性策略的成本效益比较：一项基于经济模型的系统评价
Health Technol Assess. 2006 Oct;10(38):iii-iv, xi-xiii, 1-183. doi: 10.3310/hta10380.
9
[The non-steroidal anti-inflammatory drugs].[非甾体抗炎药]
Medicina (Firenze). 1989 Jul-Sep;9(3):249-64.
10
Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis).非甾体抗炎药（包括阿司匹林和对乙酰氨基酚）在接受甲氨蝶呤治疗炎性关节炎（类风湿关节炎、强直性脊柱炎、银屑病关节炎、其他脊柱关节炎）患者中的安全性。
Cochrane Database Syst Rev. 2011 Nov 9(11):CD008872. doi: 10.1002/14651858.CD008872.pub2.
引用本文的文献
1
Immunomodulatory Effects of the Cyclooxygenase Inhibitor Lornoxicam on Phenotype and Function of Camel Blood Leukocytes.环氧化酶抑制剂氯诺昔康对骆驼血液白细胞表型和功能的免疫调节作用
Animals (Basel). 2021 Jul 6;11(7):2023. doi: 10.3390/ani11072023.
2
Fixed-Dose Combination of NSAIDs and Spasmolytic Agents in the Treatment of Different Types of Pain-A Practical Review.非甾体抗炎药与解痉药固定剂量组合治疗不同类型疼痛的实践综述
J Clin Med. 2021 Jul 15;10(14):3118. doi: 10.3390/jcm10143118.
3
Gut Microbiota in NSAID Enteropathy: New Insights From Inside.肠内菌群与 NSAID 肠病：来自内部的新见解。
Front Cell Infect Microbiol. 2021 Jul 6;11:679396. doi: 10.3389/fcimb.2021.679396. eCollection 2021.
4
Effect of different antibiotics and non-steroidal anti-inflammatory drugs on the growth of Lactobacillus casei Shirota.不同抗生素和非甾体抗炎药对干酪乳杆菌 Shirota 生长的影响。
Curr Microbiol. 2011 Mar;62(3):1028-33. doi: 10.1007/s00284-010-9819-7. Epub 2010 Nov 21.
5
[Not Available].[无可用内容]
Can Fam Physician. 1983 Dec;29:2259-61.
本文引用的文献
1
Nephrotic syndrome associated with sulindac.与舒林酸相关的肾病综合征。
N Engl J Med. 1981 Feb 12;304(7):424. doi: 10.1056/NEJM198102123040715.
2
Renal effects of fenoprofen.非诺洛芬的肾脏效应。
Ann Intern Med. 1980 Sep;93(3):508-9. doi: 10.7326/0003-4819-93-3-508.
3
Sulindac associated with pancreatitis.舒林酸与胰腺炎相关。
Ann Intern Med. 1980 Jul;93(1):151. doi: 10.7326/0003-4819-93-1-151_1.
4
Noncompliance with arthritis drugs: magnitude, correlates, and clinical implications.关节炎药物治疗的不依从性：程度、相关因素及临床意义。
J Rheumatol. 1981 Nov-Dec;8(6):931-6.
5
Healing of peptic ulcers during continuing anti-inflammatory drug therapy in rheumatoid arthritis.类风湿关节炎持续抗炎药物治疗期间消化性溃疡的愈合情况。
J Clin Gastroenterol. 1981 Mar;3(1):7-11. doi: 10.1097/00004836-198103000-00002.
6
Tolmetin. Association with reversible renal failure and acute interstitial nephritis.托美丁。与可逆性肾衰竭及急性间质性肾炎相关。
JAMA. 1981 Jul 17;246(3):243-5. doi: 10.1001/jama.246.3.243.
7
Does the frequency of daily dosage influence compliance with digoxin therapy?每日给药剂量的频率会影响地高辛治疗的依从性吗？
Br J Clin Pharmacol. 1981 Jan;11(1):31-4. doi: 10.1111/j.1365-2125.1981.tb01098.x.
8
Tolmetin-induced anaphylactoid reactions.托美丁引起的类过敏反应。
N Engl J Med. 1982 Aug 19;307(8):499-500. doi: 10.1056/NEJM198208193070815.
9
Reversible acute renal insufficiency and hyperkalemia following indomethacin therapy.吲哚美辛治疗后出现的可逆性急性肾功能不全和高钾血症。
JAMA. 1981 Jul 10;246(2):154-5.
10
Efficacy and safety of ibuprofen for hemophilic arthropathy.布洛芬治疗血友病性关节病的疗效和安全性。
Arch Intern Med. 1980 Dec;140(12):1583-5.
Zotero 插件